467 related articles for article (PubMed ID: 16752303)
1. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
Tear S; Zarkowska T
IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
[No Abstract] [Full Text] [Related]
2. BIO 2006 Annual International Convention. The expanding biotech industry of France.
Zarkowska T
IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302
[No Abstract] [Full Text] [Related]
3. BIO 2006 Annual International Convention. The current state of the global biotechnology industry.
Zarkowska T
IDrugs; 2006 Jun; 9(6):381-2. PubMed ID: 16752301
[No Abstract] [Full Text] [Related]
4. The development of China's medical biotech industry needs to be driven by innovation.
Yu Z; Dai Y
Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
6. [Chinese Sanqi industry status and development countermeasures].
Cui XM; Huang LQ; Guo LP; Liu DH
Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(4):553-7. PubMed ID: 25204122
[TBL] [Abstract][Full Text] [Related]
7. Unlocking the money-making potential of RNAi.
Howard K
Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
[No Abstract] [Full Text] [Related]
8. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
Persidis A; Persidis A
Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
[No Abstract] [Full Text] [Related]
9. Biopharmaceuticals in China.
Hu X; Ma Q; Zhang S
Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
[TBL] [Abstract][Full Text] [Related]
10. The further evolution of biotech.
Nagle T; Berg C; Nassr R; Pang K
Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
[TBL] [Abstract][Full Text] [Related]
11. Today's biotech industry in India.
Suresh N
Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
[No Abstract] [Full Text] [Related]
12. Boehringer networks to get ahead in gene therapy.
Johnson E
Nat Biotechnol; 1997 Jan; 15(1):12-3. PubMed ID: 9035095
[No Abstract] [Full Text] [Related]
13. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
14. China's unique position in discovery and preclinical research.
Boutellier R; Ullman F
Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968
[No Abstract] [Full Text] [Related]
15. [Cultivation strategy and path analysis on big brand Chinese medicine for small and medium-sized enterprises].
Wang YY; Yang HJ
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):755-8. PubMed ID: 25204160
[TBL] [Abstract][Full Text] [Related]
16. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
Hasetine W
Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
[No Abstract] [Full Text] [Related]
17. The quiet revolution.
Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
[No Abstract] [Full Text] [Related]
18. A testing approach based on tiny doses still awaits big results.
Coombs A
Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
[No Abstract] [Full Text] [Related]
19. Deal-making trends in oncology.
Moore K; Walker J
Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466
[No Abstract] [Full Text] [Related]
20. Profiles of four top biotech companies in India.
Suresh N; Rao ChS
Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
